Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
Gow
James A
JA
Song
Clara K
CK
McNamara
Tim R
TR
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000627:therapeutic use; D044482:Benzeneacetamides / Q000008:administration & dosage* / Q000627:therapeutic use; D002387:Cataract Extraction / Q000009:adverse effects; D002986:Clinical Trials as Topic / Q000379:methods; D004334:Drug Administration Schedule; D017277:Drug Approval / Q000331:legislation & jurisprudence; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000209:etiology; D010149:Postoperative Pain / Q000188:drug therapy / Q000209:etiology; D010648:Phenylacetates / Q000008:administration & dosage* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D044482:Benzeneacetamides; D010648:Phenylacetates; C414203:nepafenac